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Conjugates of estrogenic chemicals, endogenous as well
as xenobiotic, are mainly excreted via bile into the intestine.
Therefore, measurement of estrogenic activity in bile
yields useful information about an organism’s internal
exposure to (xeno-)estrogens. Although previous studies
in The Netherlands have reported estrogenic activity in male
fish bile, the contribution of natural hormones and
xenobiotic substances to this activity is unknown. To
identify compounds responsible for estrogenic activity in
fish bile, we developed a bioassay-directed fractionation
method for estrogenic chemicals. In this approach, the in
vitro reporter gene assay ER-CALUX (Estrogen Responsive
Chemical Activated Luciferase Gene Expression) was
used to assess estrogenic activity in deconjugated bile
samples and to direct RP-HPLC fractionation and chemical
analysis (by GC-MS) of estrogenic compounds. The
method was applied to bile from male breams (Abramis
brama) collected at three locations in The Netherlands. At
one of these locations, the River Dommel, extremely
high levels of plasma vitellogenin and a high incidence of
intersex gonads in these male breams have previously
been observed, indicating the exposure to estrogens. In
this study, the natural hormones 17â-estradiol, estrone, and
estriol accounted for the majority of estrogenic activity
in male bream bile. At the River Dommel, the synthetic
contraceptive pill component ethynylestradiol was found in
effective concentrations as well. The detected natural
and synthetic hormones may be responsible for the estrogenic
effects observed in wild bream from this location.
Furthermore, a large number of xenobiotic chemicals was
detected at relatively high levels in bile, including triclosan,
chloroxylenol, and clorophene. Although chloroxylenol was
shown for the first time to be weakly estrogenic, these
compounds did not contribute significantly to the estrogenic
activity observed.
Introduction
The presence of estrogenic compounds in the environment
has attracted considerable attention because of the inter-
ference these xenobiotic as well as natural chemicals may
exert on the normal functioning of human and wildlife
endocrine systems. Estrogenic compounds detected in the
environment include, for example, the natural steroid
hormones estrone (E1), 17R-estradiol (R-E2) and 17â-estradiol
(â-E2), and estriol (E3) and the synthetic steroid and
contraceptive 17R-ethynylestradiol (EE2). Industrial chemi-
cals with estrogenic properties have been detected as well,
for example, bisphenol A (BPA; used to produce epoxy resins
and polycarbonate plastics), the alkyl phenols 4-octylphenol
(4-OP) and 4-nonylphenol (NP) and their mono- and
diethoxylates (used mainly as polyethoxylates in industrial
detergents and emulsifiers). Although endogenous hormones
have been present in the environment for a very long time,
the growing population and more intensive farming have
raised the influx in aquatic systems (1). For The Netherlands,
a country densely populated by both humans (16 million
people on 45 000 km2) and livestock (18 million cattle, horses,
pigs, and sheep), an emission of the natural steroids E1, R-
and â-E2 by humans and cattle of 10 kg/d, and about 50 g/d
EE2 has been estimated (2). The annual estrogen excretion
of farm animals in urine and faeces, which, unlike human
waste, mostly does not pass sewage treatment plants, was
estimated to reach 33 t in the European Union and about 49
t in the United States (reviewed by ref 1).
The presence of estrogenic compounds in the aquatic
environment has been demonstrated numerous times
(3-8). Exposure of fish to estrogens can lead to the induction
of the precursor yolk protein vitellogenin in plasma of male
fish (8, 9). Vitellogenin (VTG) levels in male fish blood plasma,
which are usually negligible, can rise to concentrations in
the tens of milligrams per milliliter range as a result of
exposure to estrogens (10). VTG is therefore widely used as
a biomarker of estrogenic exposure (11). Moreover, mainly
in the United Kingdom, a high occurrence of intersexuality
(a condition in which oocytes are formed in the testicular
tissue) in wild populations of riverine fish has been observed
(12). This was found to be consistent with exposure to
hormonally active substances and associated with discharges
from sewage treatment plants (STPs) that are known to
contain estrogenic chemicals (13). In The Netherlands, an
investigation of the occurrence and effects of estrogenic
compounds in the aquatic environment (LOES) was recently
performed (14). The investigation showed that almost all
selected endocrine disrupting compounds (natural hor-
mones, BPA, alkyl phenols and alkyl phenol ethoxylates,
phthalates, and brominated flame retardants) were present
at low concentrations (14). At some specific locations
(especially in the vicinity of STPs), compounds were found
at higher levels. Incidence of estrogenic effects in male fish
was highest in regional surface waters that are strongly
influenced by potential sources of emission of endocrine
disrupting compounds. For example, in the River Dommel,
a small river receiving relatively high amounts of STP effluent,
extremely high plasma VTG concentrations and a high
prevalence of intersexuality in male bream (Abramis brama),
an abundant freshwater fish species in The Netherlands, were
observed (14).
Previous research has shown that measurement of
estrogenic compounds in fish bile may provide a useful
indication of internal exposure to estrogens. Caged juvenile
rainbow trout in STP effluent have been found to accumulate
estrogenic compounds in their bile, which corresponded with
large amounts of VTG in their plasma (15). Furthermore, a
good correlation was found between total bile estrogenic
activity and plasma vitellogenin induction in male bream
(16). Bile is a suitable matrix to measure internal dose due
to its role in biotransformation and elimination of com-
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pounds. In fish, estrogens are eliminated mainly by metabolic
conversion to water-soluble metabolites. Oxidative metabo-
lism of estrogens is catalyzed by cytochrome P450 enzymes
in the liver (17). For conjugation of hydroxylated metabolites
of steroids as well as xenobiotics, glucuronidation is likely
to be the dominant pathway for biliary excretion. In rainbow
trout, approximately 90% of estradiol is excreted as E2-
glucuronide (17). For the xenoestrogen 4-tert-octylphenol it
was observed that, after a 10-d exposure, 38% of the total
accumulation in the body of rainbow trout was found back
in the bile, present as glucuronides (18). A major pathway
of elimination is excretion via bile into the intestines. In the
intestines, estrogen conjugates may be broken down by
intestinal bacteria, thereby eliciting the active parent com-
pound. In the environment, estrogens are mostly found in
their biologically active parent forms, probably due to
bacterial hydrolysis of the excreted conjugates (3).
The present study was undertaken to elucidate the identity
of compounds that contribute to the high internal levels of
estrogenic activity in bream. Chemical analysis of the bile
samples was not performed in the LOES study, and com-
pounds responsible for the measured estrogenic activity in
bile remained unknown. Therefore, in this study, a toxicity
identification and evaluation (TIE) method that uses bioassay-
directed fractionation was developed for estrogenic chemicals
in fish bile. The estrogen responsive in vitro reporter gene
assay ER-CALUX (19) was used to direct the fractionation
and chemical analysis of extracts of deconjugated male fish
bile. This method was applied to bile samples of male bream
from three study locations of the Dutch LOES study. The
natural hormone 17â-estradiol was identified as the main
contributor to in vitro estrogenic activity in male fish bile.
Materials and Methods
Standards and Solvents. High purity standards of â-E2, 17â-
estradiol-3â-D-glucuronide (â-E2-gluc), E1, R-E2, E3, EE2,
4-tert-OP, BPA, cholesterol, chloroxylenol, and clorophene
(all >98% pure, except clorophene, which was 95% pure)
were purchased from Sigma-Aldrich (Zwijndrecht, The
Netherlands). NP was obtained from Acros Organics (Geel,
Belgium), and triclosan was from Ciba Specialty Chemicals
(Grenzach, Germany).
Water (H2O, HPLC analyzed), methanol (MeOH, HPLC
gradient grade), and n-hexane (Ultra resi analyzed) were
purchased from Mallinckrodt Baker (Deventer, The Neth-
erlands). Dichloromethane (DCM, Suprasolv GC quality) was
obtained from Merck (Darmstadt, Germany), ethyl acetate
(EtAc) was bought from Fluka Chemie (Buchs, Switzerland),
and dimethyl sulfoxide (DMSO, spectrofotometric grade
99.9%) was from Acros (Geel, Belgium).
Efficiency of Deglucuronidation and Extraction of
Estrogens in Bile. Portions of 1 mL of water as well as pooled
bile (obtained from nine male breams) were spiked with â-E2
(42.8 ng/mL, which represented 6-fold background level,
as established in unspiked bile) or â-E2-gluc (784.5 ng/mL
100-fold background level) and subsequently in triplicate
deconjugated in portions of 100 íL with â-glucuronidase-
sulfatase (from H. pomatia, 100 íL of 400 U/mL dissolved
in 0.2% NaCl; Sigma-Aldrich, Zwijndrecht, The Netherlands)
as described before (16). To investigate the necessity of
enzymatic deglucuronidation, similar experiments were
performed in which the enzyme solution was replaced with
100 íL of 0.2% NaCl. After deconjugation, one drop of 1 M
HCl was added. Deconjugation products were extracted by
liquid-liquid extraction with DCM or EtAc in order to
determine the solvent yielding the best extraction efficiency.
After addition of 2 mL of DCM (or EtAc), extraction tubes
were vortexed for 1 min and centrifuged for 5 min at 1500
rpm. The DCM (or EtAc) phase was subsequently removed
and transferred to another test tube. The extraction was
repeated to a total of three times, after which the collected
DCM (or EtAc) phase was carefully evaporated to a small
drop. This was quantitatively transferred into a conical vial
and taken up in 70 íL of DMSO. Glassware was prerinsed
with DCM (or EtAc) for all extraction procedures. Efficiencies
of deglucuronidation and extraction were determined by
assessment of estrogenic activity in the samples with the
ER-CALUX assay.
ER-CALUX. ER-CALUX-assay was performed with stably
transfected T47D human breast cancer cells (T47D.Luc-cells)
according to Legler et al. (19) with adaptations as described
elsewhere (20). T47D.Luc-cells were obtained from Bio-
Detection Systems B.V. (Amsterdam, The Netherlands). A
concentration series of â-E2 was included on each plate. A
sigmoidal standard curve [y ) a0 + a1/(1 + exp(-(x - a2)/
a3)); with y representing luciferase activity in relative light
units and x representing the concentration of â-E2] was fitted
using the software program Slidewrite 4.1. Bile samples were
tested in triplicate. The luciferase activities of (dilutions of)
bile samples were interpolated in the linear range of the
â-E2 standard curve. To assess the estrogenic potency of
â-E2-gluc, E1, R-E2, E3, EE2, NP, 4-tert-OP, BPA, cholesterol,
chloroxylenol, clorophene, and triclosan, concentration series
were prepared and tested in triplicate in at least two
independent experiments. For â-E2 and the other active
estrogens, half-maximum effective concentrations (EC50)
were derived from the curves. For comparison of estrogenic
potency between â-E2 and the other estrogens, the estrogenic
activity of the estrogen X was expressed relative to that of
â-E2 by calculation of the estradiol equivalence factor (EEF
value) for X with the formula EEFX ) EC50(â-E2)/EC50(X).
Study Sites. Lake Bergumermeer. Lake Bergumermeer is
a lake of some 6 km2 in the northern part of The Netherlands.
The lake and its surroundings are destined to become a nature
preservation area. On the southern side of the lake, there is
some industrial activity. A power plant is situated on the
northern side. Effluent of the STP of the small town of Bergum
is discharged in the lake. This location was chosen as reference
location. At this location female bream bile was also sampled,
extracted, and tested for estrogenicity in the ER-CALUX assay.
River Dommel. The River Dommel is a small river
originating in Belgium. It flows through an agricultural area,
several small towns, and the city of Eindhoven into the River
Dieze that runs into the Meuse. At Eindhoven, surface water
from the Dommel and STP effluent mix at an approximate
1:1 ratio.
Amsterdam North Sea Canal. The North Sea Canal forms
the connection between Amsterdam and its port in the west
and the interior freshwater Lake Ysselmeer in the east. The
canal, which flows through a heavily industrialized area, has
a port and transport function and is used for discharging
surplus water from several adjoining water board districts
and STP effluent.
Bile Sampling. Methods of bream bile sampling have been
described elsewhere (14). In brief, fish were captured in the
fall of 1999, anaesthetised with MS 222 (3-aminobenzoic acid
ethyl ester, Sigma Aldrich, Zwijndrecht, The Netherlands),
and sacrificed. After the guts were removed, samples of bile
fluid (typical volume about 2 mL) were taken with syringes.
Samples were stored in ethanol-rinsed Eppendorf cups at
-80 °C.
Deconjugation and Extraction of Bile Samples. Fish bile
samples were pooled per sex per location. Portions of 1 mL
of pooled bile were subsequently deconjugated with â-glu-
curonidase-sulfatase. Deconjugation products were extracted
by liquid-liquid extraction with DCM as described above.
The extracts were divided into two portions. Twenty percent
of the extract was evaporated and dissolved in 70 íL of DMSO
for ER-CALUX measurements. The other 80% was evaporated
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and taken up in 100 íL MeOH:H2O (1:1 v/v) for fractionation
by RP-HPLC.
RP-HPLC Fractionation. A mixture of 19 environmentally
relevant compounds (toluene (Fluka Chemie, Buchs, Swit-
zerland), 6 polycyclic aromatic hydrocarbons (PAHs: phenan-
threne, fluoranthene, naphthalene, acenaphthylene, acenaph-
thene, fluorene; Promochem, Wesel, Germany), 3 polychlori-
nated biphenyls (PCBs: 2,2′,4,5,5′-pentachlorobiphenyl (PCB
101), 2,2′,3,4,4′,5′-hexachlorobiphenyl (PCB 138), 2,2′,3,4,4′,5,5′-
heptachlorobiphenyl (PCB 180); Promochem, Wesel, Ger-
many), 4 chlorobenzenes (1,2-dichlorobenzene, 1,3-di-
chlorobenzene, 1,2,4-trichlorobenzene, and 1,2,3,4-tetra-
chlorobenzene; Sigma-Aldrich, Steinheim, Germany), chlo-
ridazone, metalaxyl (Riedel de Hae¨n, Seelze, Germany),
benzothiazole (Sigma-Aldrich, Steinheim, Germany), oc-
tachlorostyrene, and o,p′-dichlorodiphenyldichloroethane
(both from Dr. Ehrenstorfer, Augsburg, Germany) covering
a wide range of log Kow was prepared in MeOH. To 50 íL of
this mixture, 50 íL of H2O was added, and the mixture was
injected on a reversed phase high-pressure liquid chroma-
tography system with a UV detector (Shimadzu, Duisburg,
Germany, ì ) 254 nm) at 22 °C. The system was equipped
with a C18 column (Vydac TP254, 5 ím, 4.6  250 mm). The
mobile phase consisted initially of 50% MeOH and 50% H2O
(1 mL/min) and changed linearly to 100% MeOH in 50 min
according to ref 21. Retention times (Tret) were corrected for
dead volume time (T0). Corrected values (T ′ret) were cor-
related to log Kow values to obtain a standard curve from
which fraction intervals with a range of approximately one
log Kow unit were derived. Fraction border times were
determined by adding T0 to the fraction interval times and
correcting them for the volume of the tubing between detector
and fraction collector. Subsequently, a mixture of eight known
estrogenic compounds (BPA, R-E2, â-E2, E1, E3, EE2, 4-tert-
OP, and NP) in concentrations easily detectable with UV
detection (ì ) 254 nm) was injected. Retention times of the
estrogens were derived from the obtained chromatogram.
MeOH:H2O bile extracts were injected, and 10 fractions with
a range of approximately 1 log Kow unit each were collected.
These fractions were dried with N2 at 40 °C and split into
three portions. Portion A (20% of the extract weight) was
evaporated and dissolved in 70 íL of DMSO for ER-CALUX
measurements, Portion B (40%) was used for the analysis of
known estrogens. Portion C (40%) was destined for general
chemical screening using gas chromatography-mass spec-
trometry (GC-MS). After injection, the vial that had contained
the MeOH:H2O extract was rinsed with n-hexane to dissolve
the observed film of compounds presumably too nonpolar
to dissolve in MeOH:H2O prior to fractionation. This fraction
(the nonpolar residual fraction) was dissolved in 70 íL of
DMSO and tested for estrogenicity with ER-CALUX. After-
ward, to enable chemical analysis of this nonpolar extract,
this DMSO fraction was dissolved in water and nonpolar
compounds were extracted with n-hexane. The nonpolar
extract was evaporated to 100 íL. To assess the repeatability
of the partitioning of estrogenic compounds over the MeOH:
H2O and the vial surface, pooled bile from location North
Sea Canal was deglucuronidated, extracted, and dissolved in
MeOH:H2O. The extract was removed, and the vial was rinsed
with n-hexane to generate a new nonpolar residual extract.
Both the nonpolar residual extract and the MeOH:H2O
fraction were dissolved in DMSO and tested in ER-CALUX.
Chemical Analysis. Hormones and Bisphenol A. Portions
B of the RP-HPLC fractions were evaporated to dryness at
55 °C and silylated with SIL A reagent (a mixture of (CH3)3-
SiCl, (CH3)3SiNHSi(CH3)3, and pyridine in a ratio of 1:3:9;
Sigma-Aldrich, Zwijndrecht, The Netherlands) during 1 h at
55 °C. After evaporation, the residue was dissolved in
n-hexane together with the internal standard PCB 103. The
mixture was washed with water to remove byproducts that
could damage or contaminate the GC column or detector.
The n-hexane phase was dried over a sodium sulfate column
and collected in a GC conical vial. The n-hexane phase was
evaporated to 100 íL of which 3 íL was splitlessly injected
on the GC column.
Analysis was carried out on a GC-MS-MS (Varian CP3800
GC with a Varian Saturn 2200 ion trap detector), equipped
with a 30 m Varian CP-SIL 8 CB low-bleed MS column (0.25
mm i.d., 0.25 ím film thickness). The GC column was
protected with a 2-m retention gap of deactivated fused silica
0.53 mm i.d. The temperature program was as follows: initial
temperature 60 °C for 1 min, increasing linearly with 30 °C/
min to 220 °C, then at a rate of 4 °C/min to 280 °C, and 50
°C/min to the final temperature at 300 °C, with a total runtime
of 30 min. Ions for data acquisition in MS/MS mode were
for R-E2 and â-E2 derivatives m/z 416/285+326, for EE2
derivative m/z 425/193+231+303, for E1 derivative m/z 342/
257, and for E3 derivative m/z 296+311+414+504. For BPA,
only the ion with m/z ) 357 was monitored. Quantification
of hormones and BPA was performed by external calibration
using a calibration series of standards of 10 different
concentrations between 0 and 200 ng of compound/100 íL
of solvent. Standards were derivatized as described for the
bile fractions.
Chemical Screening. Portions C of RP-HPLC fractions were
evaporated until dryness and taken up in 100 íL of n-hexane.
Fractions and nonpolar residual extracts (3 íL) were splitlessly
injected on a GC-MSD (Agilent 6890 with a Agilent 5973
network quadrupole mass selective detector), equipped with
a SGE-BPX5 column (25 m, 0.22 mm i.d, 0.3 ím film thickness)
and with helium (1 mL/min) as carrier gas, operated in full-
scan mode (m/z 50-650). Mass spectra were deconvoluted
using the automated mass spectral deconvolution and
identification system AMDIS and compared with reference
spectra in the National Institute of Standards and Technology
NIST main mass spectral database (NIST/EPA/NIH Mass
Spectral Database, NIST 1992, 1998; Gaithersburg, MD)
(match factor g80) for tentative identification. To confirm
the identification of compounds, pure standards dissolved
in n-hexane were injected for the comparison of retention
time and Kovat’s Retention Indices (KRI values) with those
of the tentatively identified compounds in the extracts.
Concentrations of individual compounds were semiquan-
tified using the response of the pure standards.
Results and Discussion
Development of TIE Procedure. The TIE procedure devel-
oped for the analysis of estrogenic compounds in fish bile
(including deglucuronidation and extraction methods, RP-
HPLC fractionation, chemical analysis, and screening) is
shown schematically in Figure 1. The development of each
step of the procedure and application to field samples are
described below.
Deglucuronidation and Extraction of Estrogen Conju-
gates in Bile. Extraction of deconjugated â-E2 from water
and bile was performed by liquid-liquid extraction with DCM
or EtAc. Recoveries of estrogenic activity in the ER-CALUX
assay are shown in Table 1. Both solvents gave high,
comparable, and reproducible recoveries. DCM has a higher
volatility than EtAc and is more easily evaporated. For these
reasons, DCM was selected for the extraction of bile samples
from the study sites.
A matrix influence on the extraction was observed for
bile, as deviations from 100% recovery were larger in bile
than in water (Table 1). The extraction efficiency of decon-
jugated â-E2-gluc was higher than that of â-E2. Although the
reason for this phenomenon is unclear, it may be due to the
much higher spiking level of â-E2-gluc in the samples.
Deglucuronidation efficiency was tested by comparing
recoveries of deconjugated â-E2-gluc that had been added
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as â-E2-gluc prior to deglucuronidation to water or bile in
the presence or absence of â-glucuronidase-sulfatase (Table
1). In water, as in bile, all â-E2-gluc was deconjugated, which
confirmed the suitability of this method for further use. In
bile, some estrogenic activity was observed after deglucu-
ronidation of â-E2-gluc in the absence of added enzyme.
Because â-E2-gluc does not show any estrogenic activity
(Figure 2), this suggests the occurrence of some endogenous
hydrolysis activity in bile. This was not observed for water.
Estrogenic activity in unspiked deconjugated male bream
bile was around 17-fold higher than in untreated bile. In real
life, bream are exposed to estrogens, for example, via
consumption of food and via water passing the gills. Estrogens
can be conjugated in the liver and excreted via the bile shortly
after intake or can go into circulation before being transported
to the liver to be conjugated and excreted via the bile.
Therefore, after deglucuronidation, the estrogenic activity
in bile reflects the maximum bioavailable fraction.
RP-HPLC Fractionation. The chromatographic behavior
of a mixture of compounds of different polarity under the
RP-HPLC conditions used was estimated with a mixture of
PAHs, PCBs, chlorobenzenes, and several pesticides. As
expected according to ref 21, strong correlations were found
between the capacity factor ((Tret - T0)/T0) and log Kow (r 2
) 0.93) and between T ′ret and log Kow (r 2 )0.94; Figure 3).
This enabled the collection of fractions of bile extract
according to decreasing polarity. Selected estrogenic com-
pounds (represented by + in Figure 3) showed, although
some of them eluted relatively early, chromatographic
behavior comparable with that of the components in the
standard mixture and could thus be fractionated well by this
method. Some compounds (e.g., BPA and â-E2, having
retention times very close to the fraction borders) eluted in
neighboring fractions. Estimated Tret, fractions of elution,
and examples of log Kow values from literature (22-25) of the
estrogenic compounds are given in Table 2.
To enable comparison of estrogenic activity measured in
the ER-CALUX assay and concentrations of selected estrogens
detected with GC-MS-MS, pure standards were tested in
the ER-CALUX assay. Examples of the obtained dose-
response curves are shown in Figure 2. â-E2 and EE2 were
the most potent estrogens tested in this study. Interestingly,
TABLE 1. Recovery (Average ( SD) of Estrogenic Activity from Dichloromethane or Ethyl Acetate Extracts of 17â-Estradiol or
17â-Estradiol-3-â-D-glucuronide Spiked Male Bream Bile and Water without or after Deglucuronidation, Measured with ER-CALUXa
DCM EtAc
with enzyme
(ng of EEQ/mL)
recovery
(%)
without enzyme
(ng of EEQ/mL)
recovery
(%)
with enzyme
(ng of EEQ/mL)
recovery
(%)
without enzyme
(ng of EEQ/mL)
recovery
(%)
water 0.0 ( 0.0 - 0.0 ( 0.0 - 0.0 ( 0.0 - 0.0 ( 0.0 -
water + â-E2 42.3 ( 0.2 98.8 ( 0.5 na na 39.9 ( 4.0 93.2 ( 9.3 na na
water + â-E2-gluc 826 ( 137 105 ( 17 0.3 ( 0.1 0.0 ( 0.0 886 ( 234 113 ( 30 2.5 ( 1.8 0.3 ( 0.2
bile 7.9 ( 0.3 - 0.5 ( 0.1 - 10.4 ( 2.1 - na -
bile + â-E2 36.3 ( 3.0 72.3 ( 6.0 na na 39.8 ( 5.7 74.8 ( 10.7 na na
bile + â-E2-gluc 736 ( 55 92.9 ( 6.9 114 ( 26 14.4 ( 3.3 1112 ( 145 140 ( 24 na na
a All experiments were performed in triplicate. Recoveries in bile were corrected for background levels. Abbreviations: DCM, dichloromethane;
EtAc, ethyl acetate; EEQ, estradiol equivalents; â-E2, 17â-estradiol; â-E2-gluc, 17â-estradiol-3-â-D-glucuronide; -, recovery not applicable; na, not
assessed.
FIGURE 1. Sample treatment scheme for the toxicity identification
and evaluation of estrogenic compounds in fish bile.
FIGURE 2. Estrogenic potency of ethynylestradiol (EE), 17-â-estradiol
(E2), 17â-estradiol-3â-D-glucuronide (Gl), bisphenol A (B), chloroxy-
lenol (Cl) and triclosan (Tri) in the in vitro ER-CALUX assay.
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BPA showed supramaximal response in the ER-CALUX assay
as compared with â-E2. This might, for example, be due to
a stimulation by BPA of the production of estrogen receptor.
However, this does not affect the EC50 to a great extent.
Relative estrogenic potencies derived from EC50 values of
compounds used in the development of the fractionation
method are given in Table 2.
Application to Study Sites. Estrogenic Activity in Whole
Extracts and Polar Fractions. Although male fish are known
to have estrogenic hormones, their basal concentrations are
much lower than those in females. To confirm this, we
assessed estrogenic activity in deconjugated male as well as
female total bile extract from reference site Lake Bergumer-
meer. As expected, estrogenic activity in male bile (24.7 ( 2.0
ng of EEQ/mL of bile) was much lower than in female bile
(353 ( 17 ng of EEQ/mL of bile). The TIE procedure was then
applied to pooled male bile samples from three locations.
Large differences in estrogenic activity as measured in the
ER-CALUX assay in whole extracts of male bile were observed
between the three study locations: Lake Bergumermeer 24.7
( 2.0, River Dommel 235 ( 14, and North Sea Canal 35.6 (
2.2 ng of EEQ/mL of bile. Remarkably, fish bile from the
River Dommel showed estrogenic activity in males almost at
a female level of 1 order of magnitude higher than at the
other locations. The River Dommel was the only location
showing considerable vitellogenin induction (weighted aver-
age for this pool of samples 53.2 mg of VTG/mL, both other
locations: e0.5 E-3 mg of VTG/mL (recalculation of data
from ref 14). Also, intersex gonads (oocytes inside the
seminiferous tubules) were observed in 33% of the male
breams from this location (14). The correlation between high
responses of bile samples in the estrogen receptor mediated
ER-CALUX assay, VTG induction, and intersex suggests a
common cause of events (i.e., exposure to estrogens; 13).
Indeed, the role of the estrogen receptor in VTG induction
has been established (26), and a number of studies have
shown the correlation between VTG and effects on repro-
ductive tissues in fish (27, 28).
Fractionation of Estrogenic Activity. To determine the
nature of the estrogenic compounds in bile, whole extracts
were fractionated as described above. The distribution of
estrogenic activity over the fractions after RP-HPLC frac-
tionation is shown in Figure 4. Most estrogenic activity was
found in fractions of log Kow 2-3 and 3-4 (between 8.3 ( 0.3
ng of EEQ/mL in for North Sea Canal and 95.4 ( 7.9 ng of
EEQ/mL for River Dommel, both in fraction log Kow 2-3, see
Table 3). Unexpectedly, the nonpolar residual fraction,
obtained by rinsing the vial that had contained the MeOH:
H2O extract prior to injection on HPLC with n-hexane,
contained considerable estrogenic activity as well. Estrogenic
activities measured in these residual fractions were 2.1 ( 0.1
ng of EEQ/mL of bile for Lake Bergumermeer, 36.0 ( 5.2 ng
of EEQ/mL of bile for River Dommel and 9.9 ( 0.7 ng of
EEQ/mL of bile for the North Sea Canal. The average recovery
of estrogenic activity during fractionation, calculated by
dividing the sum of the activity in all fractions by the activity
in whole extract, was high (82 ( 22%), indicating only small
losses of estrogenic activity occur during fractionation.
Target Analysis of Known Estrogens in Polar Fractions.
Fractions with log Kow <1, 1-2, 2-3, and 3-4 were analyzed
with GC-MS-MS for the presence of the natural and synthetic
hormones and BPA. Detected concentrations of compounds
TABLE 2. Retention Time (Tret), Fraction of Elution during HPLC Fractionation, Log Kow, and Estrogenic Potencies of Eight Selected
Estrogenic Compoundsa
compound
Tret
(min)
fraction
(log Kow)b
examples of log Kow
values from literature
EEF (in vitro
ER-CALUX)
E3 6.44 1-2 (1.14) 2.45c, 2.81d 0.13
BPA 11.09 1-2, 2-3 (1.90) 3.32c, 3.64d 1.13 E-5
E1 16.91 2-3 (2.86) 3.13c, 3.43d 0.12
R-E2 16.91 2-3 (2.86) 4.01c, 3.94d 0.01
EE2 17.31 2-3 (2.92) 3.67c, 4.12d 1.12
â-E2 17.84 2-3, 3-4 (3.01) 4.01c, 3.92d, 3.10e 1
4-tert-OP 29.45 4-5, 5-6 (4.91) 5.28d, 4.12f 7.3 E-5
NP 33.60 5-6 (5.59) 5.76g, 4.48f, 5.99d 3.7 E-5
a E3, estriol; BPA, bisphenol A; E1, estrone; R-E2, 17R-estradiol; EE2, 17R-ethynylestradiol; â-E2, 17â-estradiol; 4-tert-OP, 4-tert-octylphenol; NP,
4-nonyl phenol; EEF, estradiol equivalence factor (half-maximum effect concentration of â-E2 divided by half-maximum effect concentration of
compound). b Values in parentheses indicate peak maxima (interpolated log Kow values according to correlation shown in Figure 3). c Experimental
value according to ref 22. d Estimated value according to Episuite Kowwin v1.67, U.S. EPA. e Experimental value according to ref 23. f Experimental
value according to ref 24. g Experimental value according to ref 25.
FIGURE 3. Relationship between corrected retention time (T ′ret )
retention time - dead volume time) and log Kow of polycyclic
aromatic hydrocarbons, polychlorinated biphenyls, chlorobenzenes,
and several pesticides (all marked with dots) used to calibrate
RP-HPLC elution conditions for fractionation of bile extracts (r 2 )
0.94). T ′ret of selected estrogens with literature log Kow values first
mentioned in Table 2 are represented by +.
FIGURE 4. Distribution of estrogenic activity, expressed in estradiol
equivalents (EEQ), in RP-HPLC fractions of male bream bile extracts.
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are presented in Table 3. As the estrogenic activity in fractions
with log Kow 4-5 and 5-6 was negligible, it was concluded
that 4-tert-OP and NP were not present in active amounts
and therefore dedicated 4-tert-OP and NP analyses were not
performed. To enable comparison with estrogenic activities
in the ER-CALUX bioassay, all GC-measured concentrations
were multiplied with their respective EEF values (Table 2) to
derive estrogenic activities caused by the presence of each
individual compound. This approach is based on the concept
of concentration addition as introduced in 1926 by Loewe
and Muischnek and evaluated for estrogenic compounds by
Kortenkamp and Altenburger (29). For each location, es-
trogenic activities are summed up for each fraction (columns
in Table 3) and each compound (rows in Table 3). All analyzed
compounds were detected in bile. In particular, BPA was
found in considerable concentrations (up to 3 íg/mL at
location River Dommel). However, due to its low estrogenic
potency (EEF ) 1.13 E-5), its contribution to the measured
estrogenic activity was negligible. For all three locations, most
of the activity was accounted for by â-E2. This is shown in
Figure 5. The activity of â-E2 was found in fractions log Kow
2-3 and 3-4. Its metabolite E1 was present in higher
concentrations (about 280 ng/mL at location River Dommel)
but, being less estrogenic than its parent compound (EEF )
0.12), contributed less to the total activity. The less stable
metabolite E3 and the synthetic estrogen EE2 were found
only in bile from River Dommel, albeit at relatively high
concentrations (about 37 and 17 ng/mL, respectively) (Table
3). Our results for location River Dommel are in good
agreement with the results obtained by Larsson et al. (15),
who reported the presence of â-E2, E1, EE2, BPA, and NP in
the bile of caged juvenile rainbow trout exposed to diluted
sewage effluent water in Sweden, albeit at concentrations
TABLE 3. Estrogenic Compounds Identified in Bile Extract Fractions and Associated Calculated and Measured Estrogenic
Activitiesa
fraction log Kow <1
(ng of EEQ/mL)
log Kow 1-2
(ng of EEQ/mL)
log Kow 2-3
(ng of EEQ/mL)
log Kow 3-4
(ng of EEQ/mL)
sum fractions log Kow <1-3-4
(ng of EEQ/mL)
Lake Bergumermeer
BPA 0.0 (3.9) 0.0 (28.5) - - 0.0 (32.4)
R-E2 - - 0.1 (7.7) - 0.1 (7.7)
E1 - - 17.8 (149.3) - 17.8 (149.3)
â-E2 - - 73.1 (73.1) - 73.1 (73.1)
EE2 - - - - -
E3 - - - - -
sum GCb 0.0 0.0 91.0 0.0 91.0
ER-CALUXc 0.6 0.7 18.4 3.3 22.9
GC/ER-CALUX (%)d 0.0 0.0 494.6 0.0 395.6
GC/ER-CALUXtotal (%)e 0.0 0.0 356.9 0.0 356.9
River Dommel
BPA - 0.0 (1937.6) 0.0 (42.7) - 0.0 (1980.3)
R-E2 - - 0.1 (10.1) - 0.1 (10.1)
E1 - - 33.3 (279.8) - 33.3 (279.8)
â-E2 - - 83.3 (83.3) 58.7 (58.7) 142.0 (142.0)
EE2 - - 19.5 (17.4) - 19.5 (17.4)
E3 - 0.7 (5.4) 4.1 (31.7) - 4.8 (37.1)
sum GCb 0.0 0.7 140.3 58.7 199.7
ER-CALUXc 0.1 2.5 95.4 55.5 153.5
GC/ER-CALUX (%)d 0.0 28.0 147.1 105.8 130.1
GC/ER-CALUXtotal (%)e 0.0 0.4 73.6 30.8 104.8
North Sea Canal
BPA 0.0 (4.3) 0.0 (3035.8) 0.0 (42.2) - 0.0 (3082.3)
R-E2 - - - - -
E1 - - 3.6 (30.1) - 3.6 (30.1)
â-E2 - - 8.1 (8.1) 6.7 (6.7) 14.8 (14.8)
EE2 - - - - -
E3 - - - - -
sum GCb 0.0 0.0 11.7 6.7 18.4
ER-CALUXc 0.0 0.8 8.3 5.2 14.3
GC/ER-CALUX (%)d 1.8 4.5 141.0 128.8 128.7
GC/ER-CALUXtotal (%)e 0.0 0.1 47.2 27.0 74.2
a All concentrations refer to the compounds measured in their derivatized forms and are expressed as estrogenic equivalents calculated by
multiplying concentrations with the estrogenic equivalence factor to ng of EEQ/mL of bile. Concentrations of individual compounds (ng of compound/
mL of bile) are given in parentheses. - indicates below limit of detection (LOD). LOD (ng/100 íL GC-MS-MS extract) ) 0.3 (BPA); 1.5 (17-R-E2);
1.5 (E1); 0.5 (17-â-E2); 1.5 (EE2); 1.0 (E3). b Sum of calculated estrogenic activity in ng of EEQ/mL of bile of all chemically identified compounds
per fraction. c Estrogenic activity measured in the ER-CALUX assay in ng of EEQ/mL of bile per fraction. d Estrogenic activity in ng of EEQ/mL of
bile according to GC analysis per fraction divided by estrogenic activity in the same fraction in the ER-CALUX. e Estrogenic activity in ng of EEQ/mL
of bile according to GC analysis per fraction divided by the sum of estrogenic activity in the ER-CALUX in all fractions, including the nonpolar
residual fraction.
FIGURE 5. Concentrations of identified estrogenic compounds in
fractions of male bream bile extracts, expressed as estradiol
equivalents (EEQ), based on concentrations of derivatized compounds
measured with GC-MS-MS.
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on average about 1 order of magnitude higher than those at
River Dommel.
In all three locations, measured compounds were present
in concentrations high enough to explain the estrogenic
activity in the four fractions analyzed with GC-MS-MS, with
â-E2 as major contributor. For location Lake Bergumermeer,
the total chemically identified estrogenic activity (91.0 ng of
EEQ/mL) was almost 4-fold higher than the activity found
in the ER-CALUX assay (18.4 ng of EEQ/mL). One of the
explanations for this phenomenon could be the presence of
antiestrogenic compounds in fraction log Kow 2-3 at this
location. However, when tested together with â-E2 (results
not shown), no anti-estrogenic activity in the ER-CALUX-
assay was found in this fraction.
Identification of Unknown Compounds in Nonpolar
Residual Fractions. The estrogenic activity in the four polar
fractions was explained by the presence of the compounds
measured with GC-MS-MS (Table 3). However, for locations
River Dommel and North Sea Canal, considerable estrogenic
activity in the ER-CALUX of an unknown chemical nature
was found in the nonpolar residual fractions obtained by
rinsing the vials that had contained the MeOH:H2O extracts
used for fractionation with n-hexane. To identify chemical
compounds present in these residual DMSO fractions,
chemicals were re-extracted with n-hexane and a general
chemical screen with GC-MSD was performed. Hundreds
of different spectra were deconvoluted for the nonpolar
extracts of the three locations. The presence of many
(branched and linear) alkanes, oxidized alkanes, and alkanoic
acids was suggested. Furthermore, several phenolic com-
pounds were identified. In a retention time interval between
8 and 9.5 min, numerous alkylphenolic substances and their
isomers were tentatively identified. In the nonpolar residual
fraction from the River Dommel, for example, 4-tert-OP (0.1
íg/mL of bile) was found. Furthermore, the chlorinated
phenolic disinfectants clorophene (o-benzyl-p-chlorophenol,
7 íg/mL, see Figure 6) and chloroxylenol (4-chloro-3,5-
dimethylphenol,  0.1 íg/mL) were identified in this extract.
Phthalates (especially diethylhexylphthalate with m/z )
149 as major peak with Tret ) 29.19 min and KRI ) 2534) were
found showing considerable responses. However, as phtha-
lates are notorious for contamination of samples during clean
up in the laboratory, it is doubtful if this compound really
originates from the bile, especially because it also was found
in GC-MSD screens from many more polar fractions
obtained by RP-HPLC. The fatty steroid cholesterol was
detected in nonpolar residual fractions from all locations
(see Figure 6 for the River Dommel). Concentrations were
roughly estimated to be around 230 íg/mL of bile for North
Sea Canal and 20 íg/mL of bile for River Dommel. In extract
from the North Sea Canal, several other steroidal compounds
besides cholesterol with Tret between 36 and 43 min were
tentatively identified as well (e.g., the plant sterol campesterol
and the faecal sterol epicholestanol). Although the identi-
fication of these compounds could not be confirmed because
standards were not available at our laboratories, the presence
of these endogenous and other steroids in bile is not
surprising as biliary secretion is a major excretion route for
these substances.
Triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol) was
identified in the nonpolar residual fraction from locations
River Dommel and North Sea Canal. The chromatogram peak,
spectrum, deconvoluted spectrum, and library spectrum of
triclosan are shown in Figure 6. Concentrations were about
14 íg/mL of bile for North Sea Canal and 80 íg/mL of bile
for River Dommel. This diphenyl ether is commonly used as
potent antibacterial and antifungal agent in consumer
products as toothpastes, detergents, household sponges,
socks, and underwear. The occurrence of triclosan in the
environment has been reported before by Boyd et al. (30) for
surface water and by Adolfsson-Erici et al. (31) for human
breast milk, wastewater, sewage sludge, and fish bile. Our
FIGURE 6. GC-MSD chromatogram of the nonpolar residual fraction of male bream bile from the River Dommel (top), mass spectrum at
14.07 min (middle) with the by AMDIS deconvoluted spectrum, and National Institute of Standards and Technology reference spectrum
of the adjudged substance triclosan (bottom).
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results reconfirm that this compound eventually enters the
aquatic environment, where it accumulates in fish bile.
To investigate if one or more of the identified compounds
could be responsible for the estrogenic activity in the
nonpolar residual fractions, concentration curves of identified
compounds were tested for estrogenicity in the ER-CALUX
assay. Chloroxylenol was found to be weakly estrogenic (EEF
) 2.35 E-7), as shown in the concentration response curve
in Figure 2. Concentrations tested higher than 50 íM caused
visible cytotoxicity. To our knowledge, this is the first time
the estrogenic activity of this compound has been shown.
Although this antimicrobial agent has been widely used for
years (e.g., as a disinfectant cleaning agent and preservative
in pharmaceutical and cosmetic products; 32), no reports on
the occurrence of chloroxylenol in the environment could
be found. Cholesterol, triclosan, and clorophene did not show
any estrogenic behavior in concentrations up to 0.1 mM (for
triclosan shown in Figure 2), indicating that these compounds
are not or very weakly estrogenic (EEF < 5E-8) and not able
to explain the activity measured. The concentrations in the
nonpolar residual fraction of chloroxylenol and alkylphenols
and phthalates, the only other identified compounds known
to be (weakly) estrogenic, were too low to account for the
estrogenic activity found. It is possible that trace amounts
of active estrogens were lost during the transfer of the extract
from DMSO to n-hexane for GC-MS-MS analysis. Indeed,
the extraction of â-E2 dissolved in DMSO resulted in a mere
24% recovery (data not shown).
A closer look at the polarity of the compounds detected
in the nonpolar fraction, revealed that, at the moment the
total bile extract was taken up into MeOH:H2O prior to the
HPLC-fractionation, a partitioning took place between the
polar MeOH:H2O phase and the residual liquid layer re-
maining on the vial surface. Compounds with higher log Kow
are mostly found in the nonpolar residual fraction. However,
some compounds are found in both their appropriate RP-
HPLC fraction (e.g., triclosan (log Kow ) 4.76, fraction log Kow
4-5), clorophene (log Kow ) 4.18, fraction logKow 3-4), and
cholesterol (logKow ) 8.74, found in fraction log Kow > 8)) and
in the nonpolar residual fraction. For location North Sea
Canal, 40% of the total (HPLC fractions + nonpolar residual
fraction) estrogenic activity was found in the nonpolar
residual fraction. To investigate the repeatability of the
partitioning over the MeOH:H2O and the vial surface, this
step was repeated with freshly prepared bile extract from the
North Sea Canal. Total estrogenic activity (29.4 ( 0.7 ng of
EEQ/mL of bile) was in good agreement with the total activity
measured in the TIE-study (24.8 ( 1.4 ng of EEQ/mL of bile).
However, this time 94% of the total estrogenic activity was
found in the MeOH:H2O fraction instead of 60% in the TIE
study. As the analysis of total estrogenic activity proved to
be repeatable, no activity was lost during extraction and
fractionation experiments. Only the partitioning of active
compounds between the responsive fractions differed.
Clearly, the solvent transfer of chemicals of varying polarities
as demonstrated by the transfer of bile extract from DCM to
MeOH:H2O is a delicate process that should always be
checked. However, the difference in partitioning does not
influence the compounds detected, the extent to which they
can explain estrogenic activity in their own fractions, the
comparison of total estrogenic activity between locations,
nor the interpretation concerning elevated VTG levels and
intersex prevalence.
Methodological Considerations. The TIE method de-
veloped was successfully applied to identify compounds
responsible for in vitro estrogenic activity in male bream
bile. Because of bioconcentration of estrogenic compounds
in this matrix, only 10 íL of bile is needed to detect and
quantify estrogenic activity in the ER-CALUX assay. Another
advantage of the use of bile in this study is the relatively easy
extraction and low demand on clean up for the ER-CALUX
assay and GC analysis. RP-HPLC fractionation led to a good
separation of compounds according to their polarity. The
necessity to dissolve the extract in a rather polar solvent
mixture is inherent to the chosen RP-HPLC fractionation
method. Our work shows that one should be aware of the
presence of more nonpolar estrogenic compounds, which
are incapable of completely dissolving in MeOH:H2O.
Therefore, more attention should be given to methods for
the investigation of the chemical nature of more nonpolar
estrogenic compounds. Due to the reduction of complexity
of the fractions as compared to the total extract, further
cleanup to enable GC analysis was not necessary. The
chemical screening performed with GC-MSD and AMDIS
software has shown to be a powerful tool for the tentative
identification of compounds. The concomitant use of a
sensitive GC-MS-MS method for estrogenic hormones
enabled us to investigate the contribution of the natural and
synthetic estrogenic hormones at environmentally relevant
levels. The combination of these two chemical analytical
techniques allows for analysis of the very potent known
natural and synthetic estrogens and the wide range of less
potent industrial estrogens present in environmental samples.
Causative Compounds. This study showed that, in all
three locations, the majority of the in vitro estrogenic activity
could be explained by the presence of â-E2. The occurrence
of unnaturally high concentrations of this hormone in male
bile could at least have two causes. The first one is direct
exposure of fish in the environment to â-E2, leading to uptake
and bioconcentration of â-E2 in bile. Indeed, the occurrence
of estrogenic hormones in surface waters and STP effluents
in nanograms per liter concentrations has been widely
reported (3, 5, 8, 14, 33). Another possibility is exposure to
other endocrine disrupting compounds with the potential
to disturb the metabolism of endogenous â-E2, for example,
by inducing aromatase activity (34) or inhibiting elimination
of â-E2 (35).
High biliary estrogens identified in this study correlated
well with effects in the bream sampled, including elevated
VTG plasma levels and intersexuality. However, one should
be aware of the indirectness of the analysis of endocrine
disruption causing compounds in this matrix because effects
are not expected to take place in bile but in target organs as
gonads and liver. In addition, caution should be taken when
drawing conclusions about the relative contribution of â-E2
and other estrogens present to the effects observed in bream
based on in vitro measurements. In vitro assays cannot
completely reflect complex in vivo events, such as bioavail-
ability and toxicokinetics of a compound. Therefore, con-
siderable differences between in vitro and in vivo estrogenic
potencies of compounds have been reported (36-38). For
example, although the estrogenic potencies of pure standards
of â-E2 and EE2 in the in vitro ER-CALUX assay are
comparable (36) (Figure 2); EE2 has been shown to be a 4
times more potent VTG inducer than â-E2 in zebrafish (39)
and even a hundred times more estrogenic than â-E2 in an
in vivo transgenic zebrafish assay (36). This suggests that the
involvement of EE2 in the generation of estrogenic effects is
larger than expected based on in vitro measurements.
Remarkably, the River Dommel, the only location with
elevated VTG plasma levels and intersexuality (14), is also
the only location with detectable EE2 concentrations in bile.
Estrogenic activity in bile reflects the animal’s internal
dose of estrogens. Therefore, measurement of estrogenic
compounds in bile can be a suitable approach to reduce the
gap between in vitro and in vivo measurements.
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